1. Hepatitis C virus (HCV) RNA+ liver allograft recipients invariably reinfect the liver allograft within hours after transplantation, and the majority (>70%) develop chronic hepatitis. The rate at which these patients experience progression to cirrhosis and the overall percentage are significantly
Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts
β Scribed by M Guido; M Rugge; G Leandro; I M Fiel; S N Thung
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 600 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
B virus in 2 cases, hepatitis C virus in 5), but who had not developed
The statistical analysis was performed by G. Leandro, M.D., biostatistician.
cirrhosis at the end of a comparable follow-up time (mean 30.1 Supported in part by a grant from the ''CCC'' Association Against Cancer, Cittadella, months, range 21-42).
π SIMILAR VOLUMES
In this issue, Fiel et al. 1 use the phrase "plasma cell hepatitis (de novo autoimmune hepatitis)" to describe what they eventually conclude to be a variant of acute rejection. This study was likely prompted by curiosity about the significance of plasma cell-rich infiltrates in liver allograft biops
The pathogenic mechanisms of accelerated graft fibrosis in hepatitis C recurrence after liver transplantation (LT) are not well established. The aim of the study was to assess whether a greater activation of hepatic stellate cells (HSC), the major collagen-producing cells in the liver, can occur in
prognostic features of HCC in relation to viral infection in Clinicopathological and prognostic features in papatients who had undergone hepatic resection. tients who had undergone hepatectomy for hepatocellular carcinoma (HCC) were examined in relation to viral infection. Among 175 patients, cirrho
Asahina and colleagues 1 have to be congratulated for the very interesting data and for the enormous amount of work they spent to strengthen their conclusions. The authors demonstrate that fetal mouse liver contains at least three populations of mesenchymal cells. (A) The mesothelial cells which ar
## Abstract Hepatic stellate cells (HSCs) have demonstrated a strong Tβcell inhibitory activity. In a mouse islet transplantation model, cotransplanted HSCs can protect islet allografts from rejection. The involved mechanism is not fully understood. We showed in this study that expression of tumor